Horizon Pharma Plc (HZNP)

21.54
NASDAQ : Health Technology
Prev Close 21.54
Day Low/High 0.00 / 0.00
52 Wk Low/High 12.55 / 24.03
Avg Volume 1.36M
Exchange NASDAQ
Shares Outstanding 167.63M
Market Cap 3.80B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

Under proposed transaction's terms, Horizon Pharma would acquire all outstanding shares of Depomed for $29.25 each in an all-stock transaction, a 42% premium to its closing price on Monday.

Stocks Fall as Greek Resolution Deemed Urgent

Stocks Fall as Greek Resolution Deemed Urgent

U.S. stocks extend losses after reports suggest European leaders could push Greece out of the eurozone if the debt-laden nation doesn't come up with a viable reform proposal.

Horizon Pharma (HZNP) Trading With Heavy Volume Before Market Open

Horizon Pharma (HZNP) Trading With Heavy Volume Before Market Open

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a pre-market mover with heavy volume candidate

Stock Futures Slightly Higher Ahead of Greece Summit

Stock Futures Slightly Higher Ahead of Greece Summit

U.S. stock futures rise on hopes European leaders will provide short-term liquidity to Greek banks.

Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed

Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed

Like other specialty pharmaceutical makers headquartered in tax-friendly countries, Horizon is buying growth.

10 Best Biotech Stocks in the NASDAQ

10 Best Biotech Stocks in the NASDAQ

The biotech sector has been one of the fastest growing sectors through June 30, 2015. Here are the 10 best biotech stocks this year.

New Lifetime High Reached By Horizon Pharma (HZNP)

New Lifetime High Reached By Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Horizon Pharma (HZNP) Marked As A Barbarian At The Gate

Horizon Pharma (HZNP) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Horizon Pharma (HZNP) Flagging After Hours

Horizon Pharma (HZNP) Flagging After Hours

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a post-market laggard candidate

Jim Cramer -- Micron, Other PC-Tied Chip Stocks Continue to Struggle

Jim Cramer -- Micron, Other PC-Tied Chip Stocks Continue to Struggle

TheStreet's Jim Cramer likes Horizon Pharma for more upside and says chip companies are smart to diversify their business streams.

New Lifetime High For Horizon Pharma (HZNP)

New Lifetime High For Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Jim Cramer's Top Takeaways: Verizon, Yahoo!, Horizon Pharma, Apple, Salesforce.com, Dun & Bradstreet

Jim Cramer's Top Takeaways: Verizon, Yahoo!, Horizon Pharma, Apple, Salesforce.com, Dun & Bradstreet

Why shouldn't Verizon buy Yahoo!? Cramer asks. He also likes the technical indicators for Apple and Salesforce.com.

Jim Cramer's 'Mad Money' Recap: Here Are My Dream Mergers

Jim Cramer's 'Mad Money' Recap: Here Are My Dream Mergers

Google buying Twitter? Verizon buying Yahoo!? Johnson & Johnson buying Bristol-Myers? Why not? Cramer asks.

Anything Goes in This Merger Era

If anything, I am being too small-minded when it comes to mergers.

New Lifetime High Reached By Horizon Pharma (HZNP)

New Lifetime High Reached By Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Jim Cramer's Top Takeaways: Actavis, Rite Aid, Receptos

Jim Cramer's Top Takeaways: Actavis, Rite Aid, Receptos

Cramer is impressed by Rite Aid, even though it is expensive, and Receptos, which he says is the best early-stage biotech.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer will be watching earnings from Sears, Lululemon and Cisco, among others, next week.

Where the Money Was Made the Last 5 Years

Where the Money Was Made the Last 5 Years

Only one fund category (of 20) has beaten the S&P 500 over half a decade.

New Lifetime High Reached: Horizon Pharma (HZNP)

New Lifetime High Reached: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Horizon Pharmaceuticals (HZNP) Stock is Today's 'Chart of the Day'

Horizon Pharmaceuticals (HZNP) Stock is Today's 'Chart of the Day'

Horizon Pharmaceuticals (HZNP) stock performance is the subject of today's Trifecta Stocks 'Chart of the Day' analysis.

Horizon Pharma Is Ready for a Boost

Horizon Pharma Is Ready for a Boost

Horizon Pharma's volume trends have been very positive.

Chart of the Day: HZNP

Horizon Pharma's volume trends have been very positive.

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Horizon Pharma (HZNP) Stock Tanks on Mixed Earnings

Horizon Pharma (HZNP) Stock Tanks on Mixed Earnings

Horizon Pharma (HZNP) reported first quarter earnings that missed expectations though revenue topped estimates.

'Mad Money' Lightning Round: Sell, Sell, Sell Transocean

'Mad Money' Lightning Round: Sell, Sell, Sell Transocean

Cramer says Horizon Pharmaceuticals is a winner but he's no fan of Oneok.

Jim Cramer's 'Mad Money' Recap: The 5 Ingredients in Today's Rally Recipe

Jim Cramer's 'Mad Money' Recap: The 5 Ingredients in Today's Rally Recipe

A rejuvenated stock market is still possible, Cramer says.

New Lifetime High For Horizon Pharma (HZNP)

New Lifetime High For Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Horizon Pharma (HZNP) Stock Rises in After-Hours Trading Following Pricing of Secondary Offering

Horizon Pharma (HZNP) Stock Rises in After-Hours Trading Following Pricing of Secondary Offering

Horizon Pharma (HZNP) shares are climbing in after-hours trading today after the company priced its secondary public offering at $28.25 per share.

Horizon Pharma (HZNP) Trading With Heavy Volume Before Market Open

Horizon Pharma (HZNP) Trading With Heavy Volume Before Market Open

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a pre-market mover with heavy volume candidate

Jim Cramer's 'Mad Money' Recap: 6 Positive Things You Should Keep in Focus

Jim Cramer's 'Mad Money' Recap: 6 Positive Things You Should Keep in Focus

From earnings to activist investors, Cramer said investors need to focus on the good things now happening in the markets.

TheStreet Quant Rating: B- (Buy)